Webinars
webinar
October 22nd, 2024
Optimal Strategies to Protect Commercially Confidential Information (CCI) in Clinical Documents and Report Trial Results Under Revised EU-CTIS Transparency Rules
webinar
September 26th, 2024
Regulatory Pathways for Nonprescription Drugs: A Deep Dive into OTC Monograph Reform and FDA Guidance
webinar
September 12th, 2024
No Stone Unturned: Optimizing the Use of Expedited Pathways and Oncology Center of Excellence Programs to Optimize Drug Development in Oncology
webinar
July 11th, 2024
The Rising Burden of Pharmacovigilance (PV) Requirements in Early Drug Development
webinar
June 26th, 2024
A Psychedelic Shift: Assessing the Potential for Nonmedical Use in a Changing Regulatory Landscape
webinar
March 26th, 2024
Type II Drug Master Files for Early-Stage, Small Molecule, Drug Development: Regulatory Management, Quality Considerations, and eCTD Submission
webinar
January 18th, 2024
Best Practices for Data Visualization in Pharma, presented by MMS Holdings Data Science leaders
webinar
January 18th, 2024
The Wisdom Study: Revolutionizing Breast Cancer Screening, Detection & Prevention
webinar
January 18th, 2024
Evolving Your FSP Relationships to Achieve Maximum Return
webinar
January 18th, 2024
Avoiding Common Pitfalls in the IND & CTA Submission Process
webinar
January 18th, 2024
How to Use Machine Learning in Clinical Research Right Now
webinar
January 18th, 2024
EU Clinical Trials Regulation: The Clinical Trial Transparency Revolution